Glen Eagle Advisors, LLC Atai Life Sciences N.V. Transaction History
Glen Eagle Advisors, LLC
- $603 Billion
- Q4 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 166 shares of ATAI stock, worth $330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166
Previous 166
-0.0%
Holding current value
$330
Previous $193,000
14.51%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$6.63 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$3.86 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$1.95 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.89 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $330M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...